Skip to main content

PUBLIC
BILL SUMMARY For SB23-041

HOUSE COMMITTEE ON HEALTH & INSURANCE
Date Mar 21, 2023       Location HCR 0112

SB23-041 - Postponed Indefinitely


10:05:51 AM  

Representatives Amabile and Soper, co-prime bill sponsors, presented Senate Bill 23-041 concerning the authorization of prescription drugs for off-label use. The bill authorizes prescription drugs approved by the Food and Drug Administration (FDA) for off-label use.

10:10:04 AM  
The committee asked the co-prime bill sponsors questions on the bill.
10:24:14 AM  
Mrs. Erin Meschke, representing themself, testified in support of the bill and responded to questions from the committee.
10:27:12 AM  
Nancy Eason, representing themself, testified
10:32:25 AM  
Jack Teter, representing Planned Parenthood of the Rocky Mountains, testified in opposition to the bill.

Ms. Bethany Pray, representing the Colorado Center on Law and Policy, testified in opposition to the bill.

The committee asked the panel questions.
10:53:04 AM  
The co-prime bill sponsors gave closing comments on the bill.

Committee members commented on the bill.

10:57:38 AM
Motion Refer Senate Bill 23-041 to the Committee of the Whole.
Moved Soper
Seconded Weinberg
Brown No
Garcia Excused
Hartsook Yes
Lieder No
McCormick No
Ortiz No
Soper Yes
Titone No
Weinberg Yes
deGruy Kennedy No
Daugherty No
YES: 3   NO: 7   EXC: 1   ABS:  0   FINAL ACTION:  FAIL

10:58:05 AM
Motion Postpone Senate Bill 23-041 indefinitely using a reversal of the previous roll call. There was no objection to the use of the reverse roll call, therefore, the bill was postponed indefinitely.
Moved deGruy Kennedy
Seconded Ortiz
Brown Yes
Garcia Excused
Hartsook No
Lieder Yes
McCormick Yes
Ortiz Yes
Soper No
Titone Yes
Weinberg No
deGruy Kennedy Yes
Daugherty Yes
Final YES: 7   NO: 3   EXC: 1   ABS:  0   FINAL ACTION:  PASS